Related Experiment Video
Updated: Feb 6, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
Jingying Nong1, Yuhua Gong2,3, Yanfang Guan2,3
1Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, 101149, Beijing, China.
Abstract:
Subclonal architecture and genomic evolution of small-cell lung cancer (SCLC) under treatment has not been well studied primarily due to lack of tumor specimens, particularly longitudinal samples acquired during treatment. SCLC is characterized by early hematogenous spread, which makes circulating cell-free tumor DNA (ctDNA) sequencing a promising modality for genomic profiling. Here, we perform targeted deep sequencing of 430 cancer genes on pre-treatment tumor biopsies, as well as on plasma samples collected prior to and during treatment from 22 SCLC patients. Similar subclonal architecture is observed between pre-treatment ctDNA and paired tumor DNA. Mean variant allele frequency of clonal mutations from pre-treatment ctDNA is associated with progression-free survival and overall survival. Pre- and post-treatment ctDNA mutational analysis demonstrate that mutations of DNA repair and NOTCH signaling pathways are enriched in post-treatment samples. These data suggest that ctDNA sequencing is promising to delineate genomic landscape, subclonal architecture, and genomic evolution of SCLC.
Insights
Circulating cell-free tumor DNA (ctDNA) sequencing offers a promising approach to study small-cell lung cancer (SCLC) evolution. ctDNA analysis reveals similar subclonal architecture and treatment-induced pathway enrichments, aiding in understanding SCLC genomic changes.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Small-cell lung cancer (SCLC) subclonal architecture and genomic evolution during treatment remain understudied due to limited longitudinal tumor samples.
- SCLC's propensity for early hematogenous spread highlights the potential of circulating cell-free tumor DNA (ctDNA) for non-invasive genomic profiling.
Purpose of the Study:
- To investigate the subclonal architecture and genomic evolution of SCLC using ctDNA.
- To correlate ctDNA-derived genomic features with patient survival outcomes.
- To identify genomic alterations enriched in SCLC post-treatment.
Main Methods:
- Targeted deep sequencing of 430 cancer genes was performed on pre-treatment tumor biopsies and longitudinal plasma samples from 22 SCLC patients.
- Analysis included comparison of subclonal architecture between tumor DNA and ctDNA.
- Variant allele frequencies of clonal mutations were assessed for association with progression-free and overall survival.
Main Results:
- Pre-treatment ctDNA exhibited similar subclonal architecture to paired tumor DNA.
- Mean variant allele frequency of clonal mutations in pre-treatment ctDNA correlated with patient survival.
- Post-treatment ctDNA revealed enrichment of mutations in DNA repair and NOTCH signaling pathways.
Conclusions:
- ctDNA sequencing is a viable tool for characterizing the genomic landscape and subclonal architecture of SCLC.
- ctDNA analysis can provide insights into the genomic evolution of SCLC under treatment.
- Genomic alterations in DNA repair and NOTCH pathways are potentially associated with SCLC treatment response or progression.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
06:19Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
Published on: July 18, 2017
Related Concept Videos
Genome Size and the Evolution of New Genes
Genome Size and the Evolution of New Genes
Genomics
The Evidence for Evolution
Genomic DNA in Prokaryotes
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Genomic DNA in Eukaryotes